VITRAKVI (larotractenib) oral solution, 20mg/mL, 100 mL bottle, Rx only, Manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ 07981. NDC 50419-392-01
Published December 6, 2023 · Recall initiated: November 6, 2023
Summary
FDA records drug Class I recall D-0145-2024, published December 6, 2023 and initiated November 6, 2023. Recalling firm: Bayer Healthcare Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 192 bottles; Lot: Lot# 2114228, EXP. 02/29/2024. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing
What to do
Voluntary: Firm initiated · Letter
Get an email if VITRAKVI has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VITRAKVI
- Manufacturer
- Bayer Healthcare Pharmaceuticals Inc.
- Distributor
- Product was distributed to specialty pharmacies and distributors nationwide who may have further distributed the product.
- Lot
- Lot# 2114228, EXP. 02/29/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count bottle NDCDecember 6, 2023
- FDAArtri King Reforzado con Origa y Omega 3 tablets, packaged in 100-count bottles, Manufactured by: PlantasDecember 6, 2023
- FDAPAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; b)1000-count bottle, NDCDecember 6, 2023
- FDAReumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV,December 6, 2023
- FDAPAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDCDecember 6, 2023
- FDAKuka Flex Forte caplets, packaged in 30-count bottles, Manufactured by: Kukamonga, Gonzalez Ortega No 170 ColDecember 6, 2023
Questions about this recall
Was VITRAKVI (larotractenib) oral solution, 20mg/mL, 100 mL bottle, Rx only, Manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ 07981. NDC 50419-392-01 recalled?
Yes. FDA published recall D-0145-2024 on December 6, 2023. Reported hazard: Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VITRAKVI.